Literature DB >> 21859302

Drug discovery for neglected tropical diseases at the Sandler Center.

Stephanie A Robertson1, Adam R Renslo.   

Abstract

The Sandler Center's approach to target-based drug discovery for neglected tropical diseases is to focus on parasite targets that are homologous to human targets being actively investigated in the pharmaceutical industry. In this way we attempt to use both the know-how and actual chemical matter from other drug-development efforts to jump start the discovery process for neglected tropical diseases. Our approach is akin to drug repurposing, except that we seek to repurpose leads rather than drugs. Medicinal chemistry can then be applied to optimize the leads specifically for the desired antiparasitic indication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859302      PMCID: PMC3199145          DOI: 10.4155/fmc.11.85

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  32 in total

Review 1.  Protein kinase inhibitors: insights into drug design from structure.

Authors:  Martin E M Noble; Jane A Endicott; Louise N Johnson
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

2.  Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes.

Authors:  Priyadarshini Jaishankar; Elizabeth Hansell; Dong-Mei Zhao; Patricia S Doyle; James H McKerrow; Adam R Renslo
Journal:  Bioorg Med Chem Lett       Date:  2007-11-22       Impact factor: 2.823

3.  Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.

Authors:  Chiung-Kuang Chen; Siegfried S F Leung; Christophe Guilbert; Matthew P Jacobson; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2010-04-06

4.  Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.

Authors:  Zachary B Mackey; Arthur M Baca; Jeremy P Mallari; Beth Apsel; Anang Shelat; Elizabeth J Hansell; Peter K Chiang; Brian Wolff; Kiplin R Guy; Janice Williams; James H McKerrow
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

5.  Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.

Authors:  Lívia de Figueiredo Diniz; Ivo Santana Caldas; Paulo Marcos da Matta Guedes; Geovam Crepalde; Marta de Lana; Cláudia Martins Carneiro; André Talvani; Julio Alberto Urbina; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

6.  Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases.

Authors:  Clifford Bryant; Iain D Kerr; Moumita Debnath; Kenny K H Ang; Joseline Ratnam; Rafaela S Ferreira; Priyadarshini Jaishankar; DongMei Zhao; Michelle R Arkin; James H McKerrow; Linda S Brinen; Adam R Renslo
Journal:  Bioorg Med Chem Lett       Date:  2009-09-03       Impact factor: 2.823

7.  Development of and access to products for neglected diseases.

Authors:  Joshua Cohen; Maria Staroselsky Dibner; Andrew Wilson
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

Review 8.  Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections.

Authors:  Frederick S Buckner
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

9.  Ergosterol biosynthesis and drug development for Chagas disease.

Authors:  Julio A Urbina
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

10.  Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.

Authors:  Chiung-Kuang Chen; Patricia S Doyle; Liudmila V Yermalitskaya; Zachary B Mackey; Kenny K H Ang; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more
  4 in total

Review 1.  Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery.

Authors:  Arijit Bhattacharya; Audrey Corbeil; Rubens L do Monte-Neto; Christopher Fernandez-Prada
Journal:  Genes (Basel)       Date:  2020-06-29       Impact factor: 4.096

Review 2.  Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases.

Authors:  Minna Allarakhia
Journal:  Drug Des Devel Ther       Date:  2013-08-08       Impact factor: 4.162

3.  A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.

Authors:  Victoria Gillan; Kerry O'Neill; Kirsty Maitland; Francis M Sverdrup; Eileen Devaney
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

4.  A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.

Authors:  Ariel José Berenstein; María Paula Magariños; Ariel Chernomoretz; Fernán Agüero
Journal:  PLoS Negl Trop Dis       Date:  2016-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.